“The first plan enabled these partnerships to flourish and gave a shared understanding of the work needed to mould a single service.

“The time is now right to build on this early work and set out a new phase of activity for the next three years.”

Professor Hamish Wallace, national clinical director for MSN CYPC, said: “The objective is for all young patients with cancer to receive the right diagnosis, be treated with the right treatment, by the right team in the right place on their cancer journey and that they will always have the opportunity to participate in any national or international cancer clinical trial for which they are eligible.

“The most important driver for this is setting standards of care to achieve the very best clinical outcomes, whilst putting the needs of the patient and their loved ones at the centre.”